These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9284781)

  • 1. Differential transmission of HIV-1 and HIV-2.
    Christiansen CB; Albert J; Machuca R; Nielsen C
    Lancet; 1997 Aug; 350(9077):562. PubMed ID: 9284781
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-1 infection in a man homozygous for CCR5 delta 32.
    O'Brien TR; Winkler C; Dean M; Nelson JA; Carrington M; Michael NL; White GC
    Lancet; 1997 Apr; 349(9060):1219. PubMed ID: 9130945
    [No Abstract]   [Full Text] [Related]  

  • 3. CCR5-delta 32 gene deletion in HIV-1 infected patients.
    Wang B; Palasanthiran P; Zeigler J; Cunningham A; Saksena NK
    Lancet; 1997 Sep; 350(9079):742. PubMed ID: 9291932
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group.
    Theodorou I; Meyer L; Magierowska M; Katlama C; Rouzioux C
    Lancet; 1997 Apr; 349(9060):1219-20. PubMed ID: 9130946
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV-1-resistant individuals may lack HIV-1 coreceptor.
    Bradbury J
    Lancet; 1996 Aug; 348(9025):463. PubMed ID: 8709791
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance to HIV-1 infection: it's in the genes.
    Fauci AS
    Nat Med; 1996 Sep; 2(9):966-7. PubMed ID: 8782446
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural resistance to HIV?
    Hill CM; Littman DR
    Nature; 1996 Aug; 382(6593):668-9. PubMed ID: 8751431
    [No Abstract]   [Full Text] [Related]  

  • 8. 32 bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes.
    Rappaport J; Cho YY; Hendel H; Schwartz EJ; Schachter F; Zagury JF
    Lancet; 1997 Mar; 349(9056):922-3. PubMed ID: 9093257
    [No Abstract]   [Full Text] [Related]  

  • 9. Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry.
    Doms RW; Peiper SC
    Virology; 1997 Sep; 235(2):179-90. PubMed ID: 9281497
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV-1 infection in an individual homozygous for the CCR5 deletion allele.
    Biti R; Ffrench R; Young J; Bennetts B; Stewart G; Liang T
    Nat Med; 1997 Mar; 3(3):252-3. PubMed ID: 9055842
    [No Abstract]   [Full Text] [Related]  

  • 11. Serial dilutions on synthetic peptide-based assays can resolve dual seroreactivity to HIV-1 and HIV-2.
    Soriano V; Gutiérrez M; Heredia A; Bravo R; Aguilera O; Mas A; Hewlett I; Baquero M; González-Lahoz J
    Vox Sang; 1996; 71(1):67-8. PubMed ID: 8837364
    [No Abstract]   [Full Text] [Related]  

  • 12. CC-chemokine receptor 5 genotypes and in vitro susceptibility to HIV-1 of a cohort of British HIV-exposed uninfected homosexual men.
    Aarons E; Fernandez M; Rees A; McClure M; Weber J
    AIDS; 1997 Apr; 11(5):688-9. PubMed ID: 9108955
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic tests: Human immunodeficiency virus type 1, type 2 (HIV-1, HIV 2)].
    Fujii T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():434-7. PubMed ID: 16111295
    [No Abstract]   [Full Text] [Related]  

  • 14. Intact CCR-5 coreceptors in HIV-1-infected chimpanzees.
    ten Haaft PJ; Murthy KK; Verstrepen BE; Eichberg JW; Heeney JL
    AIDS; 1997 Aug; 11(10):1291-3. PubMed ID: 9256948
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV CCR5 resistance incomplete.
    Smith O
    Nat Med; 1997 Apr; 3(4):372-3. PubMed ID: 9095162
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tracking down natural resistance to HIV. Defective cellular receptor prevents entrance of virus into the cell].
    Hobom B
    Fortschr Med; 1996 Oct; 114(29):12, 14. PubMed ID: 9005198
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethics of AIDS study.
    Gomperts ED; Donfield SM
    Science; 1996 Dec; 274(5293):1596. PubMed ID: 8984621
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV type 1 coreceptors, neutralization serotypes, and vaccine development.
    Moore J; Trkola A
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):733-6. PubMed ID: 9171216
    [No Abstract]   [Full Text] [Related]  

  • 19. Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group.
    Garred P; Eugen-Olsen J; Iversen AK; Benfield TL; Svejgaard A; Hofmann B
    Lancet; 1997 Jun; 349(9069):1884. PubMed ID: 9217763
    [No Abstract]   [Full Text] [Related]  

  • 20. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India.
    Cecilia D; Kulkarni SS; Tripathy SP; Gangakhedkar RR; Paranjape RS; Gadkari DA
    Virology; 2000 Jun; 271(2):253-8. PubMed ID: 10860879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.